Research archive
Research published in 2016
76 publications from 2016, newest first.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
- StudyVeterinaryJ Am Vet Med Assoc2016 Dec 15Incidence of sterile hemorrhagic cystitis in tumor-bearing dogs concurrently treated with oral metronomic cyclophosphamide chemotherapy and furosemide: 55 cases (2009-2015).Chan CM, et al.
- StudyMath Biosci Eng2016 Dec 1Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases.Shah AB, et al.
- Clinical trialBreast Cancer Res Treat2016 DecMetronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.Cazzaniga ME, et al.
- Case reportDig Liver Dis2016 DecHigh-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art.Falcone R, et al.
- Clinical trialInvest New Drugs2016 DecClinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.Di Desidero T, et al.
- Randomized trialClin Colorectal Cancer2016 DecAssociation Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial.Marchetti P, et al.
- Clinical trialBMC Cancer2016 Nov 22Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.Wong ET, et al.
- StudyElife2016 Nov 18Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Qi S, et al.
- StudyEcancermedicalscience2016Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Pantziarka P, et al.
- StudyJ Clin Diagn Res2016 NovMetronomic Chemotherapy: Seems Prowess to Battle against Cancer in Current Scenario.Muthusamy P, et al.
- Case reportVeterinaryJ Am Vet Med Assoc2016 Nov 1Primary nodal hemangiosarcoma in four dogs.Chan CM, et al.
- StudyAnticancer Drugs2016 NovThe TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer.Romiti A, et al.
- ReviewNat Rev Clin Oncol2016 NovPharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.Bocci G and Kerbel RS
- StudyJ Immunother Cancer2016Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.Weir GM, et al.
- StudyCancer Res2016 Oct 15Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy.Shaked Y, et al.
- Phase 3 trialBMC Cancer2016 Oct 10SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.Rochlitz C, et al.
- StudyCancer Chemother Pharmacol2016 OctImpact of metronomic neoadjuvant chemotherapy on early tongue cancer.Kina S, et al.
- StudyCancer Chemother Pharmacol2016 OctThe metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin's lymphoma.Zeng J, et al.
- Clinical trialJ Neurooncol2016 OctPhase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma.McCracken DJ, et al.
- StudyEcancermedicalscience2016Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.Rosé A, et al.
- StudyCancer Res2016 Aug 15Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.Cadamuro M, et al.
- StudyBMC Cancer2016 Aug 11Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators.Wu J, et al.
- Clinical trialMed Oncol2016 AugMetronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial.Calcagno F, et al.
- Randomized trialInvest New Drugs2016 AugA phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.Swiecicki PL, et al.
- StudyActa Paediatr2016 AugMetronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential.Porkholm M, et al.
- StudyOncoimmunology2016mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.Borch TH, et al.
- StudyIndian J Palliat Care2016 Jul-SepSpecialist Pediatric Palliative Care Referral Practices in Pediatric Oncology: A Large 5-year Retrospective Audit.Ghoshal A, et al.
- Phase 3 trialBreast Cancer Res Treat2016 JulTumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.Pruneri G, et al.
- StudyCancer Med2016 JulCan metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?Heng MA, et al.
- StudyCurr Oncol2016 JunMetronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours.Ali AM and El-Sayed MI
- StudyMol Clin Oncol2016 JunIndication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.Kontani K, et al.
- Randomized trialInvest New Drugs2016 JunRandomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.Kummar S, et al.
- ReviewExpert Opin Pharmacother2016 JunTubulin inhibitors in non-small cell lung cancer: looking back and forward.Ferrara R, et al.
- Clinical trialJ Transl Med2016 May 6GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.Pietrantonio F, et al.
- Case reportJ Transl Med2016 May 3Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.De Divitiis C, et al.
- Clinical trialPLoS One2016Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.Sutiman N, et al.
- ReviewGeburtshilfe Frauenheilkd2016 MayMetronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature.Banys-Paluchowski M, et al.
- Systematic reviewFuture Oncol2016 MayMaintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.Rossi S, et al.
- Clinical trialFuture Oncol2016 MayQuality of life in patients with metastatic breast cancer treated with metronomic chemotherapy.Perroud HA, et al.
- Clinical trialJ Neurooncol2016 MayCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.Khasraw M, et al.
- StudyClin Cancer Res2016 May 1Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.Yang W, et al.
- StudyAm J Respir Crit Care Med2016 May 1Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.Cornelissen R, et al.
- Clinical trialBMC Cancer2016 Apr 20A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.Elharrar X, et al.
- StudySouth Asian J Cancer2016 Apr-JunWeekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer.Noronha V, et al.
- StudySouth Asian J Cancer2016 Apr-JunTolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin.Dessai SB, et al.
- StudySouth Asian J Cancer2016 Apr-JunOutcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience.Pandey A, et al.
- StudySouth Asian J Cancer2016 Apr-JunMetronomic palliative chemotherapy in maxillary sinus tumor.Patil VM, et al.
- StudySouth Asian J Cancer2016 Apr-JunOutcome of operable oral cavity cancer and impact of maintenance metronomic chemotherapy: A retrospective study from rural India.Pandey A, et al.
- StudySouth Asian J Cancer2016 Apr-JunAn audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients.Patil VM, et al.
- StudyEBioMedicine2016 AprEffective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.Pasquier E, et al.
- CommentaryAging (Albany NY)2016 AprMetronomic chemotherapy for triple negative breast cancer?Di Desidero T, et al.
- StudyCancer Lett2016 Apr 1CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.Jordan M and Waxman DJ
- Randomized trialSupport Care Cancer2016 AprHealth-related quality of life in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of the head and neck in India.Noronha V, et al.
- Case reportJ Oncol Pharm Pract2016 AprMetronomic maintenance chemotherapy in patients presenting with paraneoplastic autoimmune hepatitis with recurrent thymic carcinoma.Kivrak Salim D, et al.
- StudyOncotarget2016 Mar 29Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Morscher RJ, et al.
- ReviewJ Med Case Rep2016 Mar 14An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.Gagliato Dde M, et al.
- Case reportSurg Neurol Int2016Primary atypical teratoid/rhabdoid tumor of the spine in an adult patient.Li L, et al.
- StudyProstate Int2016 MarChemotherapy in frail elderly patients with hormone-refractory prostate cancer: A "real world" experience.Tralongo P, et al.
- StudyInt J Gynecol Cancer2016 MarContinuous Low-Dose Oral Cyclophosphamide and Methotrexate as Maintenance Therapy in Patients With Advanced Ovarian Carcinoma After Complete Clinical Response to Platinum and Paclitaxel Chemotherapy.El-Husseiny K, et al.
- StudyAnticancer Drugs2016 MarCellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cells.Biziota E, et al.
- StudyJ Exp Clin Cancer Res2016 Feb 13Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.Sun C, et al.
- ReviewBreast Care (Basel)2016 FebDose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic Index.Schmidt M
- Case reportMedicine (Baltimore)2016 FebComplete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case Report.Di Lorenzo G, et al.
- StudyPLoS One2016Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.Ouyang M, et al.
- Randomized trialCancer Immunol Immunother2016 FebA randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.Noguchi M, et al.
- Clinical trialCancer Chemother Pharmacol2016 FebMetastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response.Perroud HA, et al.
- ReviewFuture Oncol2016 FebMetronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.Cazzaniga ME, et al.
- Clinical trialAnticancer Drugs2016 FebPhase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.Reynés G, et al.
- StudyAnticancer Drugs2016 FebA metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer.Roberto M, et al.
- ReviewOncology2016Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.Patil VM, et al.
- ReviewCurr Pharm Des2016Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer.Sales ME
- Clinical trialAnticancer Res2016 JanMETRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.Launay S, et al.
- Randomized trialInt J Hyperthermia2016Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.Wang-Yuan Z, et al.
- StudyVeterinaryVet Radiol Ultrasound2016 JanHYPOFRACTIONATED RADIOTHERAPY FOR MACROSCOPIC CANINE SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY OF 50 CASES TREATED WITH A 5 × 6 GY PROTOCOL WITH OR WITHOUT METRONOMIC CHEMOTHERAPY.Cancedda S, et al.
- Phase 3 trialAnn Oncol2016 JanA randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial.Hagman H, et al.
- Clinical trialClin Transl Oncol2016 JanProspective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).Wang X, et al.